Dissecting shared genetic risk across the spectrum of Alzheimer’s and Lewy body dementia: effects of APOE ε4 on structural imaging measures and cognition

Please join us …

When: Tuesday, March 1, 2022, 12–1 p.m.

Where: Join Zoom Meeting https://us06web.zoom.us/j/86044633057, Meeting ID: 860 4463 3057. Meeting password: 112233

Who: Mario Masellis, MSc. (Pharm), MD, PhD, FRCPC; Associate Professor (Neurology), U of T; Clinician Scientist, Sunnybrook Research Institute

Topic: Dissecting shared genetic risk across the spectrum of Alzheimer’s and Lewy body dementia: effects of APOE ε4 on structural imaging measures and cognition

Learning objectives

1. Understand clinical and pathological heterogeneity in neurodegenerative diseases and how this has hampered the development of disease-modifying agents
2. Example of dissecting shared genetic risk for the Alzheimer’s/Lewy body disease spectrum through the use of genotype-endophenotype associations

Mario Masellis